InvestorsHub Logo
Followers 1004
Posts 43238
Boards Moderated 0
Alias Born 03/17/2014

Re: Invest-in-America post# 62

Tuesday, 01/31/2023 9:41:48 AM

Tuesday, January 31, 2023 9:41:48 AM

Post# of 114
$CNTX:

Context Therapeutics' Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU(TM) (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
7:30 am ET January 31, 2023 (Globe Newswire) Print
GlobeNewswireJanuary 31, 2023


First endocrine innovation in more than 20 years which has shown improved efficacy over standard-of-care treatments in patients with advanced breast cancer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CNTX News